ArticleAustralian prescriber2021
Reporting adverse drug events to the Therapeutic Goods Administration.
Article in Australian prescriber, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed.
- Consumers' experiences and perspectives on reporting adverse drug reactions using digital tools: a qualitative study.International journal of clinical pharmacy · 2026Article
- Glucagon-like peptide-1 receptor agonists and venous thromboembolism: an unresolved question for Australian prescribers.Internal medicine journal · 2026Article
- Article
- Complementary Medicine Use and Perceptions of It in Victoria, Australia: A Statewide Cross-Sectional Survey.Nutrients · 2026Article
- Exploring Complementary Medicine Usage, Consumer Perceptions, and Impact of Label Warnings: A Cross-Sectional Study in Melbourne, Australia.Pharmacy (Basel, Switzerland) · 2025Article
- Co-Designing a Consumer-Focused Digital Reporting Health Platform to Improve Adverse Medicine Event Reporting: Protocol for a Multimethod Research Project (the ReMedi Project).JMIR research protocols · 2025Article
- Consumers' knowledge and experiences of adverse drug reaction reporting in Australia: a national survey.European journal of clinical pharmacology · 2024Article
- TGAAustralian prescriber · 2024Article
- Limitations of randomised controlled trials as evidence of drug safety.Australian prescriber · 2023Article
- Article
- Consumer-Generated Discourse on Cannabis as a Medicine: Scoping Review of Techniques.Journal of medical Internet research · 2022Article
- Vaccine safety: what systems are required to ensure public confidence in vaccines?The Medical journal of Australia · 2022Article
- NSW Cannabis Medicines Advisory Service preliminary survey results: enquirer perceptions and patient outcomes.Internal medicine journal · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.